Raymond James & Associates’s Crinetics Pharmaceuticals CRNX Stock Holding History

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q3	$376K	Buy	7,358 +494	+7%	+$25.2K	﹤0.01%	3252
2024 Q2	$307K	Buy	6,864 +236	+4%	+$10.6K	﹤0.01%	3337
2024 Q1	$310K	Buy	+6,628	New	+$310K	﹤0.01%	3333